ArticleTherapeutics and clinical risk management2007

Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom.

Anna Raber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.